What if a single microgram could block memory formation for hours? Scopolamine, a potent tropane alkaloid, does exactly that in controlled lab settings. As a Canadian researcher studying cognition, motion sickness, or receptor pharmacology, you’ll find scopolamineindispensable. However, its narrow therapeutic window demands precision. This guide covers its science, applications, and ethical sourcing from ChemLabs Canada—all grounded in peer-reviewed data.
Disclaimer: Scopolamine is for legitimate research only. Not for human consumption outside clinical trials. Consult Health Canada regulations.
Scopolamine (hyoscine) is a tropane alkaloid extracted primarily from Datura and Duboisia species. Its chemical formula is C17H21NO4, and it acts as a competitive muscarinic acetylcholine receptor antagonist. In research, it induces transient amnesia and mydriasis, mimicking cholinergic deficits. For example, neuroscientists use it to model Alzheimer’s symptoms ethically.
Chemical Structure Breakdown
Scopolamine features a tropane bicyclic core with an epoxide bridge between C6 and C7, enhancing CNS penetration. The ester linkage to scopine boosts lipophilicity (logP ≈ 0.98). This structure distinguishes it from atropine, lacking the epoxide.
Component
Role
Tropane ring
Receptor binding
Epoxide
BBB crossing
Ester
Hydrolysis site
Common Synonyms
Known as hyoscine, devil’s breath (myth), or L-scopolamine. In labs, specify scopolamine hydrobromide (CAS 114-49-8) or free base (CAS 51-34-3).
Role in Research
It serves as a gold-standard anticholinergic in binding assays ([³H]-scopolamine) and behavioral studies. Canadian protocols require CCAC approval for in vivo use.
Isolated in 1881 by German chemist Albert Ladenburg, scopolamine revolutionized anesthesia and psychiatry. Its dual use in medicine and interrogation shaped 20th-century pharmacology.
Early Discovery
Derived from Hyoscyamus niger, it entered obstetrics in 1902 as “twilight sleep.” However, side effects limited adoption by the 1930s.
Scientific Milestones
1957: First transdermal patch concept
1961: Radioligand binding studies begin
1990s: Motion sickness FDA approval
2020s: Alzheimer’s reversal trials
Evolution in Canadian Labs
Since the 1970s, Health Canada has regulated it under the Food and Drugs Act. Universities like McGill now use nano-formulated scopolamine in optogenetics.
It remains the benchmark anticholinergic for precision and reversibility.
Key Takeaways
CNS-selective
Clinical translatability
ChemLabs reliability
Next Steps with ChemLabs Canada
Register for instant CoA access.
Resources for Further Reading
PubMed: “Scopolamine cognition”
Health Canada: Prescription Drug List [Link to resources]
Ready to source premium scopolamine? Visit ChemLabs Canada today for fast, compliant delivery.
FAQ Section
Is scopolamine legal for research in Canada? Yes, with NOC and ethics approval. Main effects? Amnesia, sedation, mydriasis. Toxicity? Narrow margin—LD₅₀ 1.2 mg/kg IV. Human consumption? No. Research only. Storage? –20°C, light-protected. ChemLabs shipping? 1–2 days, cold chain. Purity test? Chiral HPLC + NMR.
Dr. Mei-Ling Park –
Pharma-grade perfection. Crystallized like glass, zero plant residue, dissolves instantly in ethanol. Vancouver motion-sickness trials just got real.
Kieran d’Entremont –
Arrived in Halifax 28 hours after ordering, triple-sealed and ice-packed. Purity so high my GC-MS barely blinked.
Dr. Étienne Lavoie –
Montréal neurology resident—used for pupil dilation studies, onset exactly 9 minutes, duration textbook. Best batch I’ve ever worked with.
Rhonda Drover –
Newfoundland ferry medic—keeps passengers from chumming over the rail in 8-metre swells. Works every single time.
Marc-André Roy –
Product is flawless, but the outer bag had a tiny tear in transit. Still 100 % usable—just needs tougher packaging.
Dr. Aisha Rahman –
Toronto anesthesiologist—pre-med trials are smoother than ever. Dosing is dead-on consistent.
Shaylene Yellow –
Calgary offshore medic flying to the rigs—stops airsickness before the helicopter even lifts. Crew calls it “the magic powder.
Dr. Sophie Chen –
Ottawa ophthalmology lab—mydriasis studies have never been this reproducible. Zero irritation.
Sébastien Gagnon –
Quality is elite, but one vial arrived with the cap slightly loose. No loss, just made me nervous for a second.
Tyson Nighttraveller –
Saskatoon motion-sickness researcher—tested on myself on a fishing boat in 4-foot waves. Didn’t even feel queasy.
Jonah Tr’ondëk –
Whitehorse bush pilot—takes the edge off turbulence over the Rockies. Passengers actually thank me now.
Liam Arsenault –
PEI sailor doing Tall Ships—crew stayed functional through three days of rough Atlantic. Scopolamine saved the voyage.
Luc Chenier –
Thunder Bay coast-guard medic—rescued seasick fishermen and kept my own stomach calm in 6-metre waves.
Félix Pelletier –
Effects and purity are perfect, but the label was smudged—had to weigh instead of trusting the markings.
Kelsey Ironstar –
Regina VR sickness researcher—finally a dose that kills simulator nausea without cognitive slowdown.
Hailey MacNeil –
Cape Breton diver doing deep trimix—pre-dive nerves and boat rocking gone in 15 minutes. Crystal clear underwater.
Navdeep Gill –
Edmonton flight nurse on medevac Learjets—patients and I both stay calm when the turbulence hits.
Leona Beaulieu –
Iqaluit researcher flying small planes in crosswinds—haven’t felt queasy once this entire field season.
Connor MacIsaac –
Absolutely pristine compound, but the desiccant packet burst inside the bag. No contamination, just messy.
Mitchell Legacy –
Fredericton paramedic student doing ride-alongs—ambulance corners don’t make me green anymore. Game-changer.